Kuan-wei Huang
Hsinchu, TNQ 30068, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Disordered DNA-binding motif forms a modulation site for inhibiting the cancer immunotherapy target TREX1.
Journal: Nucleic acids research
Published: October 28, 2025
CXCR4 antagonist-loaded nanoparticles reprogram the tumor microenvironment and enhance immunotherapy in hepatocellular carcinoma.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: October 03, 2024
Membrane Protein Modification Modulates Big and Small Extracellular Vesicle Biodistribution and Tumorigenic Potential in Breast Cancers In Vivo.
Journal: Advanced materials (Deerfield Beach, Fla.)
Published: September 28, 2022
Long noncoding RNA Smyca coactivates TGF-β/Smad and Myc pathways to drive tumor progression.
Journal: Journal of hematology & oncology
Published: March 01, 2022
Targeted Covalent Inhibitors Allosterically Deactivate the DEDDh Lassa Fever Virus NP Exonuclease from Alternative Distal Sites.
Journal: JACS Au
Published: September 24, 2021
Delivery of sorafenib by myofibroblast-targeted nanoparticles for the treatment of renal fibrosis.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: September 19, 2021
A multifunctional nanocarrier for efficient TRAIL-based gene therapy against hepatocellular carcinoma with desmoplasia in mice.
Journal: Hepatology (Baltimore, Md.)
Published: February 07, 2017
Showing 1-9 of 9
Last Updated: 09/26/2026